Each week All IN for Health is sharing breaking health news stories on our social media platforms. Take a look at this week’s breaking health news story, and previous weeks, below.
The National Institutes of Health has awarded $217 million to fund research at Indiana University School of Medicine in the current fiscal year.
As we prepare for the midweek storm, it’s important to keep yourself safe not only indoors, but also outdoors. The American Heart Association is encouraging Hoosiers to protect themselves while shoveling snow and to know the signs of a heart attack.
As COVID-19 at-home tests start popping up in mailboxes, the federal government is also shipping out millions of free N95 masks to stores across the country.
The Biden administration said it is the largest deployment of personal protection equipment in U.S. history.
The 400 million non-surgical N95 masks are coming from the Strategic National Stockpile and are being sent to health centers and pharmacies across the country. Some are expecting shipments this week.
The Biden administration on Tuesday quietly launched its website for Americans to request free at-home COVID-19 tests, a day before the official launch.
Chlorthalidone, a low-cost prescription drug, has been around for more than 60 years. It was approved by the FDA to treat high-blood pressure in 1960, but there was still an unknown component.
As the nation grapples with a dramatic rise in COVID-19 cases and a shortage of rapid tests, Indiana is limiting who can undergo rapid testing at its sites to those most at risk and to schoolchildren looking to return to the classroom.
Over the weekend, health officials in Indiana confirmed the first case of the omicron variant in the state. The arrival of the highly infectious variant – now identified in at least 45 states – comes when hospitals across Indiana are already facing critical shortages.
BLOOMINGTON, Ind. (AP) — The Irsay family is donating $3 million to Indiana University for a new research institute on the Bloomington campus that will focus on addressing the stigma surrounding mental health issues.
The first confirmed case of the omicron variant in the U.S. was identified Wednesday, a little more than a week after its initial discovery in South Africa. While the World Health Organization has already listed omicron as a variant of concern, experts are still trying to learn about the new strain.
Pfizer announced Tuesday that it had entered an agreement with the UN that will expand access of its new COVID-19 antiviral pill to millions of people in poorer countries upon its approval.
Alzheimer’s disease research programs at IU School of Medicine collaborate on disease models, drug discovery of gene
INDIANAPOLIS — Investigators from two of Indiana University School of Medicine’s largest funded research programs are collaborating on a study investigating the biology behind a gene associated with Alzheimer’s disease, with the hopes of developing a drug to treat the disease.
AstraZeneca's COVID-19 vaccine trial results published in NEJM, IU School of Medicine being one of the study sites
Pharmaceutical giant, AstraZeneca, has published its COVID-19 vaccine data in the highly credible scientific journal, New England Journal of Medicine. Results published in the journal show that the vaccine known as AZD1222 is a safe and effective way to prevent people from getting symptomatic cases of COVID-19. More than 32,000 adults participated in the study, where they received two doses of the vaccine, four weeks apart